Orforglipron (Foundayo) in Ireland: The Oral Weight Loss Pill Explained

Orforglipron (brand name Foundayo) is an investigational once-daily oral weight loss pill that is currently undergoing Phase 3 clinical trials and is not yet available for prescription in Ireland. When approved by European regulators, this non-peptide GLP-1 receptor agonist will offer an oral alternative to injectable weight management treatments like Mounjaro and Saxenda.

Irish patients seeking medical weight management often prefer tablets over weekly injections. This guide explains how Orforglipron works, its current development status, and what alternative treatments are presently licensed in Ireland.

What is Orforglipron (Foundayo)?

Orforglipron is a new chemical entity designed to help adults manage chronic weight issues. It is developed by the pharmaceutical company Eli Lilly. Unlike existing GLP-1 treatments that use peptides, Orforglipron is a non-peptide small molecule. This structure allows the active medicine to survive digestion in the stomach.

Patients take the medication as a single daily tablet. It does not require strict fasting before or after ingestion. The medication acts on the GLP-1 receptor to mimic natural satiety hormones. This process helps to reduce appetite and slow down stomach emptying.

Is Orforglipron available in Ireland yet?

No, Orforglipron is not currently available in Irish pharmacies. The drug has not yet received marketing authorisation from the European Medicines Agency (EMA) or the Health Products Regulatory Authority (HPRA) in Ireland.

The drug is currently in Phase 3 clinical trials, which are known as the ATTAIN trials. These trials evaluate the safety, efficacy, and long-term tolerability of the drug. Regulatory submission is expected after these trials conclude. A public launch in Ireland is not anticipated for some time.

How does the daily oral weight loss pill work?

Orforglipron works by targeting the glucagon-like peptide-1 (GLP-1) receptor in the body. When you eat, your gut naturally releases GLP-1 hormones to signal fullness to your brain. Orforglipron mimics this signal to help you feel satisfied with smaller portions of food.

It also slows the rate at which your stomach empties its contents. This delay helps to prolong the feeling of fullness after a meal. By managing appetite and reducing cravings, the daily tablet supports patients in maintaining a calorie-restricted diet.

What weight loss options are currently licensed in Ireland?

While Orforglipron is still in clinical development, Irish patients can access other licensed medical treatments. These treatments must be prescribed by a registered general practitioner following a clinical consultation.

Currently approved weight loss medications in Ireland include:

• Liraglutide (Saxenda): A daily injectable GLP-1 receptor agonist.
• Tirzepatide (Mounjaro): A weekly injectable dual GIP and GLP-1 receptor agonist.
• Semaglutide (Wegovy): A weekly injectable GLP-1 receptor agonist.

All prescription weight loss medications must be used alongside a reduced-calorie diet and increased physical activity. You can read more about healthy lifestyle changes on the HSE website.

To access these treatments safely, patients should consult with a medical professional. You can verify that your doctor is registered by visiting the Irish Medical Council register. If you wish to discuss your suitability for current treatments, you can book online GP consultations in Ireland through our secure platform.

What are the safety rules for medical weight loss?

Prescription weight management medications are not suitable for everyone. Doctors assess patients based on their Body Mass Index (BMI) and the presence of weight-related health conditions. These conditions include type 2 diabetes, high blood pressure, and sleep apnoea.

Common side effects of GLP-1 medications include nausea, diarrhoea, constipation, and acid reflux. These symptoms are usually mild and improve over time.

If you experience severe abdominal pain, persistent vomiting, or signs of a severe allergic reaction, you must seek emergency medical care immediately. Please call 999 or 112, or visit your nearest hospital emergency department in these circumstances.

For patients looking to discuss their health goals, NOVAGP offers expert medical weight loss support with registered Irish doctors.

Consult an Irish Registered GP

If you are considering medical weight management, you can discuss your health goals and currently licensed treatment options with an online GP.

Consider booking a €39 GP consultation with NOVAGP today. Consultations are conducted via secure phone or video with Irish-registered doctors. There is no subscription fee and no app download required. Please note that all prescriptions and treatments are subject to a thorough clinical assessment by the GP, and a prescription is never guaranteed.

Related care with NOVAGP

• Contraceptive pill — smart prescription — clinician-reviewed, sent to your pharmacy.
• Check your symptoms in 30 seconds — free, no sign-up.

Share this guide